Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

'tAnGo', A Phase III Randomised Trial Of Gemcitabine In Paclitaxel-Containing, Epirubicin-Based, Adjuvant Chemotherapy For ER/PgR-Poor, Early Stage, Breast Cancer

NCT00039546 is registered in ClinicalTrials.gov with Cancer Research Campaign Clinical Trials Centre as lead sponsor.

NCT NCT00039546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00039546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
'tAnGo', A Phase III Randomised Trial Of Gemcitabine In Paclitaxel-Containing, Epirubicin-Based, Adjuvant Chemotherapy For ER/PgR-Poor, Early Stage, Breast Cancer
Lead sponsor
Cancer Research Campaign Clinical Trials Centre
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2001
Completion date
Not reported
Enrollment
Not reported
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer